 |
| Handing over blood pressure monitors to healthcare facilities |
The program is being implemented under the guidance of the International Society of Hypertension (ISH) and the World Heart Federation (WHF), with support from sponsors OMRON and the Servier Pharmaceutical Research Institute.
Hypertension is currently regarded as one of the world’s most significant public health challenges. According to data presented at the event, this disease affects approximately 1.3 billion people and is responsible for around 7.5 million deaths annually. Alarmingly, nearly half of those living with hypertension are unaware of their condition, increasing the risk of serious complications such as stroke, heart failure, and kidney failure.
Findings from the MMM 2025 campaign underscored the critical importance of hypertension screening. The program screened over 300,000 people and recorded a hypertension prevalence rate of 34.9%. It also identified a significant proportion of participants with comorbidities, including diabetes (14.1%), heart failure (3.6%), stroke (2.3%), and kidney failure (1.8%). Meanwhile, 84.3% of diagnosed patients were receiving treatment, and 64.1% had their blood pressure effectively controlled, reflecting the positive impact of community-based management, monitoring, and treatment efforts.
One of the highlights of this year’s launch ceremony was the donation of 80 OMRON digital blood pressure monitors to 40 health stations across the city. The equipment will provide practical support for primary healthcare facilities, helping strengthen their capacity for the early detection, management, and monitoring of hypertension patients.